Home/Filings/4/0001415889-23-009951
4//SEC Filing

MCCLUSKI STEPHEN C 4

Accession 0001415889-23-009951

CIK 0000855654other

Filed

Jun 15, 8:00 PM ET

Accepted

Jun 16, 4:48 PM ET

Size

8.3 KB

Accession

0001415889-23-009951

Insider Transaction Report

Form 4
Period: 2023-06-14
Transactions
  • Award

    Restricted Stock Unit

    2023-06-14+13,09013,090 total
    Exercise: $0.00Common Stock (13,090 underlying)
  • Award

    Stock Option (right to buy)

    2023-06-14+19,59719,597 total
    Exercise: $17.72Exp: 2033-06-14Common Stock (19,597 underlying)
Footnotes (4)
  • [F1]The restricted stock units ("RSUs") were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors, as amended, and the 2018 Employee, Director and Consultant Equity Incentive Plan, as amended. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  • [F2]The restricted stock units vest on the one-year anniversary of the date of grant, contingent upon the individual remaining a director as of the vesting date.
  • [F3]The stock options were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors, as amended, and the 2018 Employee, Director and Consultant Equity Incentive Plan, as amended.
  • [F4]The stock options vest ratably on each of 9/1/23, 12/1/23, 3/1/24, and 6/1/24, contingent upon the individual remaining a director as of each vesting date.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001188728

Filing Metadata

Form type
4
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:48 PM ET
Size
8.3 KB